Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study

Antonio Lanzone, Daniela Romualdi, Simona De Cicco, Maurizio Guido

Risultato della ricerca: Contributo in rivistaArticolo in rivista

18 Citazioni (Scopus)

Abstract

The estrogenic component of estro- progestin (EP) is responsible for a negative impact on the metabolic and lipid assessment in women with polycystic ovary syndrome (PCOS).
Lingua originaleEnglish
pagine (da-a)636-641
Numero di pagine6
RivistaJournal of Endocrinological Investigation
Volume36
Stato di pubblicazionePubblicato - 2013

Keywords

  • ethynil-estradiol

Fingerprint

Entra nei temi di ricerca di 'Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study'. Insieme formano una fingerprint unica.

Cita questo